structure of Tazarotenic acid

Tazarotenic acid

CAS No.: 118292-41-4
M. Wt: 323.409
M. Fa: C19H17NO2S
InChI Key: IQIBKLWBVJPOQO-UHFFFAOYSA-N
Appearance: Yellow Solid

Names and Identifiers of Tazarotenic acid

CAS Number

118292-41-4

IUPAC Name

6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylic acid

InChI

InChI=1S/C19H17NO2S/c1-19(2)9-10-23-17-8-4-13(11-16(17)19)3-6-15-7-5-14(12-20-15)18(21)22/h4-5,7-8,11-12H,9-10H2,1-2H3,(H,21,22)

InChIKey

IQIBKLWBVJPOQO-UHFFFAOYSA-N

Canonical SMILES

CC1(CCSC2=C1C=C(C=C2)C#CC3=NC=C(C=C3)C(=O)O)C

UNII

85FDJ14553

Physical and chemical properties of Tazarotenic acid

Acidity coefficient

3.30±0.10(Predicted)

Boiling Point

527.5±50.0 °C at 760 mmHg

Density

1.3±0.1 g/cm3

Exact Mass

323.097992

Flash Point

272.9±30.1 °C

Index of Refraction

1.671

LogP

4.95

Melting Point

>190°C (dec.)

Molecular Formula

C19H17NO2S

Molecular Weight

323.409

PSA

75.49000

Solubility

DMSO (Slightly, Sonicated), Methanol (Slightly, Sonicated)

Storage condition

2-8°C

Vapour Pressure

0.0±1.5 mmHg at 25°C

Applications of Tazarotenic acid

Tazarotenic acid is primarily utilized in dermatological treatments for:

  • Plaque Psoriasis: Reduces scaling and inflammation associated with the disease.
  • Acne Vulgaris: Normalizes keratinocyte differentiation and reduces comedone formation.
  • Photodamaged Skin: Improves skin texture and reduces signs of aging.

It has also shown potential in reducing atypical melanocytes, which are precursors to skin cancer, thereby providing a protective effect against certain skin malignancies.

Interaction Studies of Tazarotenic acid

Studies have demonstrated that tazarotenic acid interacts selectively with retinoic acid receptors (RARα, RARβ, RARγ), influencing gene expression related to skin cell behavior. Its efficacy is enhanced when combined with other treatments (e.g., topical corticosteroids), particularly in psoriasis management. Furthermore, minimal systemic absorption suggests that most effects are localized to the site of application, reducing the risk of systemic side effects.

Biological Activity of Tazarotenic acid

Tazarotenic acid exhibits significant biological activity through its interaction with retinoic acid receptors, particularly RAR-β and RAR-γ. It modulates gene expression related to keratinocyte proliferation and differentiation, leading to therapeutic effects in skin conditions characterized by abnormal keratinocyte behavior. Specifically, it downregulates markers associated with inflammation and keratinocyte hyperproliferation, making it effective in treating psoriasis and acne. Additionally, long-term use has been associated with increased collagen production and improved skin structure.

Physical sample testing spectrum (NMR) of Tazarotenic acid

Physical sample testing spectrum (NMR) of Tazarotenic acid

Retrosynthesis analysis of Tazarotenic acid

  • Route#1

    Cas:118292-40-3
    Cas:118292-41-4
  • Route#2

    Cas:952294-17-6
    Cas:118292-41-4